Metabolic Effects of Exogenous 3-hydroxybutyrate in Patients With Type 1 Diabetes and Healthy Controls

Patients with type 1 diabetes:

Inclusion criteria

• Type 1 diabetes diagnosis
• C-peptide negative
• 19 < BMI < 26
• written consent

Exclusion criteria

• Severe comorbidity
• Regular medication apart from insulin (except over-the-counter medicines)
• Use of long acting insulin analogues, that work > 24 hours, e.g. Tresiba
• PI finds the patient not fit (e.g. mental illness, too nervous, unacceptable screening blood tests or other).

Healthy control subjects:

Inclusion criteria

• 19 < BMI < 26
• written consent

Exclusion criteria

• Chronic disease
• Regular medication (except over-the-counter medicines)
• PI finds the patient not fit (e.g. mental illness, too nervous, unacceptable screening blood tests or other).